Polar Capital Holdings Plc Has $128.60 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Polar Capital Holdings Plc lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 14.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 246,379 shares of the medical equipment provider's stock after selling 40,034 shares during the quarter. Polar Capital Holdings Plc owned about 0.07% of Intuitive Surgical worth $128,600,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $82,517,000. Sycomore Asset Management grew its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock worth $9,214,000 after buying an additional 4,079 shares during the period. China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the period. Finally, Truist Financial Corp grew its position in shares of Intuitive Surgical by 3.0% during the 4th quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock worth $129,494,000 after buying an additional 7,298 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on ISRG shares. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Royal Bank of Canada lowered their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Barclays lowered their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Finally, Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $598.95.

Insider Activity

In other news, EVP Myriam Curet sold 2,401 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total value of $1,394,981.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $205,093. This trade represents a 87.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,700 shares of company stock worth $16,865,621 over the last ninety days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

ISRG traded up $3.32 during trading on Friday, reaching $563.60. The company had a trading volume of 1,422,176 shares, compared to its average volume of 1,644,552. Intuitive Surgical, Inc. has a 12 month low of $395.60 and a 12 month high of $616.00. The business's fifty day moving average price is $505.22 and its 200 day moving average price is $536.61. The company has a market cap of $202.00 billion, a P/E ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.